Physician profile

Sonela Blaceri

Cardiovascular Disease · Dearborn, MI

NPI 1942640347

$10,185.23

in general payments reported to CMS, 2019-2025

42 companies · $1,837 in 2025

The $1,837 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,637.05

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,344.90 2019-2025 Lifevest
Boston Scientific Corporation $1,187.85 2019
Abbott Laboratories $1,062.66 2019-2023 Pressurewire
Janssen Pharmaceuticals, INC $797.85 2019-2024 Xarelto
Inari Medical, INC. $766.25 2023-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Astrazeneca Pharmaceuticals LP $506.62 2019-2025 Wainua, Farxiga
Tactile Systems Technology INC $458.82 2021-2025 Flexitouch Plus, Entre Plus, Nimbl
Stryker Corporation $413.12 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt
Abiomed $399.52 2022-2025 Impella
Merck Sharp & Dohme LLC $383.63 2021-2025 Verquvo
Cardiovascular Systems INC. $358.58 2019-2021
Novartis Pharmaceuticals Corporation $297.26 2021-2025
Novo Nordisk INC $291.43 2022-2025 Wegovy, Ozempic, Rybelsus
Medtronic, INC. $245.58 2022-2025 Turbohawk, Symplicity G3, Onyx Frontier
Boehringer Ingelheim Pharmaceuticals, INC. $184.36 2021-2025 Jardiance
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Alnylam Pharmaceuticals INC. $122.23 2024-2025 Amvuttra
Sanofi-Aventis U.S. LLC $121.41 2019-2023
Lexicon Pharmaceuticals, INC. $114.15 2023-2024 Inpefa
E.R. Squibb & Sons, L.L.C. $101.23 2024-2025 Camzyos, Eliquis
Astellas Pharma US INC $99.95 2021
Kestra Medical Technology Services, INC. $85.68 2025 Assure Wcd
Amgen INC. $82.07 2020-2024 Repatha
Terumo Medical Corporation $75.65 2020-2024 Angio-Seal, Tr Band
Amarin Pharma, INC. $64.92 2020-2021
Actelion Pharmaceuticals US, INC. $58.24 2023-2024 Opsumit, Uptravi
Bayer Healthcare Pharmaceuticals INC. $56.64 2021-2024
Pfizer INC. $54.68 2023-2025
Bard Peripheral Vascular, INC. $54.58 2021-2022
Esperion Therapeutics, INC. $49.66 2023-2025 Nexletol
Scpharmaceuticals INC. $42.03 2023-2025
Impulse Dynamics (USA) INC. $37.09 2023 Optimizer
Azurity Pharmaceuticals, INC. $36.82 2024-2025 Edarbi
Heartflow, INC. $33.00 2023 Ffrct
Bridgebio Pharma, INC. $26.39 2025 Attruby
Biotronik INC. $25.11 2019
Kiniksa Pharmaceuticals, LTD. $23.44 2023 Arcalyst
Kiniksa Pharmaceuticals International, Plc $23.28 2024 Arcalyst
United Therapeutics Corporation $21.97 2024 Tyvaso
Siemens Medical Solutions USA, INC. $20.97 2022
Cardinal Health 200 LLC $19.96 2020
Philips North America LLC $18.63 2022
Inspire Medical Systems, INC. $17.02 2025 Inspire

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sonela Blaceri

$10,185.23

in general payments reported 2019-2025

Years
2019-2025
Top company
Zoll Services LLC (A/K/A Zoll Lifecor Corp)
Context
The $1,837 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/178602/sonela-blaceri

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.